At a time when biotech incubators and shared spaces are beginning to multiply in Manhattan, work on what could rank among the city’s largest biotech centers—if it can all come together—is just getting underway.
According to Paul Wexler, a longtime healthcare-focused real estate broker, construction should begin next year on what is being called the “New York Life Sciences and Biotechnology Center.” The plans for this complex, situated on 41st Street and 1st Avenue, are ambitious: Wexler says the center, when completed, would total 1.35 million square feet, which would be one of the largest facilities in Manhattan devoted exclusively to life sciences. It’s meant to have a mix of biotech and pharma companies, large and small, and would have a floor devoted to incubator space ready for seed stage companies right when it opens. A Website outlining some of the scant details so far is now up and running.
“We’re doing all of the due diligence to find out what people would like,” Wexler says. “The fact of the matter is this is going to be New York’s most exciting life sciences and biotech project.”
Read Complete Article